Explore the words cloud of the TEXAD project. It provides you a very rough idea of what is the project "TEXAD" about.
The following table provides information about the project.
Coordinator |
EXOGENUS THERAPEUTICS SA
Organization address contact info |
Coordinator Country | Portugal [PT] |
Total cost | 115˙000 € |
EC max contribution | 115˙000 € (100%) |
Programme |
1. H2020-EU.2.3.2.2. (Enhancing the innovation capacity of SMEs) |
Code Call | H2020-INNOSUP-2019-02 |
Funding Scheme | CSA |
Starting year | 2019 |
Duration (year-month-day) | from 2019-12-30 to 2020-12-29 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | EXOGENUS THERAPEUTICS SA | PT (CANTANHEDE) | coordinator | 115˙000.00 |
Exogenus Therapeutics is a drug development company using an exosome-based platform technology to develop an innovative pipeline of therapeutic products. Exogenus’ scientific team has pioneer research work in the area of Umbilical Cord Blood (UCB)-derived Extracellular Vesicles (EVs) clinical application. Among EVs, exosomes are nanosized vesicles (30-150nm) released from all types of cells responsible for cell-to-cell communication. Exogenus’ technology makes use of UCB cells preconditioned in ischemia, which secrete EVs enriched in pro-regenerative, anti-inflammatory and immunomodulatory biomolecules. Based on immunomodulatory properties of the lead biological active agent under development (Exo-101), and its capacity to increase immunotolerance, the company is investigating the potential of these vesicles for the treatment of autoimmune diseases. There are more than 80 different autoimmune diseases (AD) and a prevalence of more than 50 million people in the US alone. There is a high unmet need for most of these diseases, especially regarding safer treatments with less secondary effects. Based on their proprietary vesicles derived from UCB, Exogenus aims to develop a new generation of biologics for AD, with high efficacy and less secondary effects.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TEXAD" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "TEXAD" are provided by the European Opendata Portal: CORDIS opendata.
Provision of innovative support services to Armenian SMEs which potential for growth and innovation development.
Read More‘Key account management’ for the EIC Pilot beneficiaries and ‘Enhancing SME innovation management capacity’ as proinnovative services for SMEs in the regions of Southern Poland
Read More